111 related articles for article (PubMed ID: 26834049)
1. High mobility group box 1 is increased in the sera of psoriatic patients with disease progression.
Bergmann C; Strohbuecker L; Lotfi R; Sucker A; Joosten I; Koenen H; Körber A
J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):435-41. PubMed ID: 26834049
[TBL] [Abstract][Full Text] [Related]
2. Increased dermal expression of chromatin-associated protein HMGB1 and concomitant T-cell expression of the DNA RAGE in patients with psoriasis vulgaris.
Strohbuecker L; Koenen H; van Rijssen E; van Cranenbroek B; Fasse E; Joosten I; Körber A; Bergmann C
Psoriasis (Auckl); 2019; 9():7-17. PubMed ID: 30859087
[TBL] [Abstract][Full Text] [Related]
3. Increased HMGB1 serum levels and altered HMGB1 expression in patients with psoriasis vulgaris.
Chen T; Guo ZP; Li L; Wang L; Jia RZ; Cao N; Qin S; Li MM
Arch Dermatol Res; 2013 Apr; 305(3):263-7. PubMed ID: 23440398
[TBL] [Abstract][Full Text] [Related]
4. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.
Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M
Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436
[TBL] [Abstract][Full Text] [Related]
5. Increased level of high mobility group box 1 in the serum and skin in patients with generalized pustular psoriasis.
Watanabe T; Yamaguchi Y; Watanabe Y; Takamura N; Aihara M
J Dermatol; 2020 Sep; 47(9):1033-1036. PubMed ID: 32613742
[TBL] [Abstract][Full Text] [Related]
6. Level of secreted HMGB1 correlates with severity of inflammation in chronic rhinosinusitis.
Min HJ; Kim SJ; Kim TH; Chung HJ; Yoon JH; Kim CH
Laryngoscope; 2015 Jul; 125(7):E225-30. PubMed ID: 25639490
[TBL] [Abstract][Full Text] [Related]
7. Factors masking HMGB1 in human serum and plasma.
Urbonaviciute V; Fürnrohr BG; Weber C; Haslbeck M; Wilhelm S; Herrmann M; Voll RE
J Leukoc Biol; 2007 Jan; 81(1):67-74. PubMed ID: 17060363
[TBL] [Abstract][Full Text] [Related]
8. Could serum HMGB1 levels be a predictor associated with psoriatic arthritis?
Yildirim D; Baykul M; Edek YC; Gulengul M; Alp GT; Eroglu FS; Adisen E; Kucuk H; Erden A; Goker B; Nas K; Ozturk MA
Biomark Med; 2023 Oct; 17(20):871-880. PubMed ID: 38117143
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of HMGB1 protects against the development of acute lung injury after severe acute pancreatitis.
Luan ZG; Zhang XJ; Yin XH; Ma XC; Zhang H; Zhang C; Guo RX
Immunobiology; 2013 Oct; 218(10):1261-70. PubMed ID: 23706497
[TBL] [Abstract][Full Text] [Related]
10. Measuring serum levels of high-mobility group box 1 by enzyme-linked immunosorbent assay does not identify bacterial infections in patients with systemic lupus erythematosus.
Tang KT; Hsieh TY; Chen YM; Hsieh CW; Chen YH; Chen DY
Lupus; 2014 Aug; 23(9):926-34. PubMed ID: 24704776
[TBL] [Abstract][Full Text] [Related]
11. HMGB1 in systemic lupus Erythematosus: Its role in cutaneous lesions development.
Abdulahad DA; Westra J; Limburg PC; Kallenberg CG; Bijl M
Autoimmun Rev; 2010 Aug; 9(10):661-5. PubMed ID: 20546955
[TBL] [Abstract][Full Text] [Related]
12. Anti-high mobility group box 1 (anti-HMGB1) antibodies are not related to the occurrence of cutaneous lesions in systemic lupus erythematosus.
Tan G; Zhu N; Shi Z; Meng Z; Yu M; Li K; Yin J; Wei K; Mi X; Wang L
Scand J Rheumatol; 2015; 44(2):150-6. PubMed ID: 25439526
[TBL] [Abstract][Full Text] [Related]
13. High mobility group box1 (HMGB1) in relation to cutaneous inflammation in systemic lupus erythematosus (SLE).
Abdulahad DA; Westra J; Reefman E; Zuidersma E; Bijzet J; Limburg PC; Kallenberg CG; Bijl M
Lupus; 2013 May; 22(6):597-606. PubMed ID: 23549344
[TBL] [Abstract][Full Text] [Related]
14. Production of recombinant human HMGB1 and anti-HMGB1 rabbit serum.
Lin Q; Fang J; Fang D; Li B; Zhou H; Su SB
Int Immunopharmacol; 2011 Jun; 11(6):646-51. PubMed ID: 21255697
[TBL] [Abstract][Full Text] [Related]
15. The role of intracellular high-mobility group box 1 in the early activation of Kupffer cells and the development of Con A-induced acute liver failure.
Yang Q; Liu Y; Shi Y; Zheng M; He J; Chen Z
Immunobiology; 2013 Oct; 218(10):1284-92. PubMed ID: 23706499
[TBL] [Abstract][Full Text] [Related]
16. High mobility group box 1 in the pathogenesis of inflammatory and autoimmune diseases.
Voll RE; Urbonaviciute V; Herrmann M; Kalden JR
Isr Med Assoc J; 2008 Jan; 10(1):26-8. PubMed ID: 18300566
[TBL] [Abstract][Full Text] [Related]
17. [Expression of high mobility group box-1 in the lung tissue and serum of patients with pulmonary tuberculosis].
Yang XM; Yang H
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jul; 36(7):497-500. PubMed ID: 24262084
[TBL] [Abstract][Full Text] [Related]
18. The role of high mobility group box chromosomal protein 1 in rheumatoid arthritis.
Chen Y; Sun W; Gao R; Su Y; Umehara H; Dong L; Gong F
Rheumatology (Oxford); 2013 Oct; 52(10):1739-47. PubMed ID: 23584368
[TBL] [Abstract][Full Text] [Related]
19. High-mobility group box-1 in sterile inflammation.
Tsung A; Tohme S; Billiar TR
J Intern Med; 2014 Nov; 276(5):425-43. PubMed ID: 24935761
[TBL] [Abstract][Full Text] [Related]
20. High mobility group box-1 protein in patients with suspected community-acquired infections and sepsis: a prospective study.
Gaïni S; Pedersen SS; Koldkjaer OG; Pedersen C; Møller HJ
Crit Care; 2007; 11(2):R32. PubMed ID: 17346334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
